Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF).
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. J Crit Care. 2023 Aug;76:154301. doi: 10.1016/j.jcrc.2023.154301. Epub 2023 Apr 12. J Crit Care. 2023. PMID: 37059003 Free article.
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia.
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. Int J Antimicrob Agents. 2023 Nov;62(5):106992. doi: 10.1016/j.ijantimicag.2023.106992. Epub 2023 Sep 29. Int J Antimicrob Agents. 2023. PMID: 37778429 No abstract available.
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia.
Gatti M, Giannella M, Rinaldi M, Gaibani P, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. Antibiotics (Basel). 2022 Dec 2;11(12):1739. doi: 10.3390/antibiotics11121739. Antibiotics (Basel). 2022. PMID: 36551398 Free PMC article.
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae.
Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: gaibani p. J Glob Antimicrob Resist. 2023 Sep;34:268-270. doi: 10.1016/j.jgar.2023.05.007. Epub 2023 Jun 1. J Glob Antimicrob Resist. 2023. PMID: 37269975 Free article. No abstract available.
Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species.
Bianco G, Boattini M, Comini S, Gaibani P, Cavallo R, Costa C. Bianco G, et al. Among authors: gaibani p. Eur J Clin Microbiol Infect Dis. 2024 Mar;43(3):559-566. doi: 10.1007/s10096-024-04745-7. Epub 2024 Jan 19. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38240988
146 results